Omnicell, Inc OMCL Securities Lawsuit

Company:	Omnicell, Inc
Ticker Symbol:	OMCL
Class Period:	May-2-14 to Mar-2-15
Date Filed:	May-4-15
Lead Plaintiff Deadline:	Jul-3-15
Court:	Northern District of California
Allegations:

San Francisco, CA: A securities class action lawsuit has been filed against Omnicell, Inc. ("Omnicell" or the "Company") OMCL, -and certain of its officers. The class action, filed in United States District Court, Northern District of California, and docketed under 15-cv-01280, is on behalf of a class consisting of all persons or entities who purchased Omnicell securities between May 2, 2014 and March 2, 2015, inclusive (the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act").

Omnicell, Inc. provides automation solutions for medication and supply management. The company operates in two segments, Acute Care and Non-Acute Care.

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements, as well as failed to disclose material adverse facts pertaining to arrangements with certain customers. Specifically, defendants made false and/or misleading statements and/or failed to disclose: (1) the existence of a "side letter" arrangement with a Company customer for certain discounts and Company products that were to be provided at no cost, but which were not reflected in the final invoices paid by the customer; (2) that the Company lacked adequate internal controls over financial reporting; and (3) that as a result of the foregoing, the Company's financial statements were materially false and misleading at all relevant times.

On March 2, 2015, after the market closed, the Company disclosed in a regulatory filing that it would be unable to timely file its Annual Report on Form 10-K for the year ended December 31, 2014. According to the Company, "additional time is required by the Company to investigate a notice received on February 27, 2015 from a Company employee alleging, among other matters, the existence of a 'side letter' arrangement with a Company customer for certain discounts and Company products that were to be provided at no cost, but which were not reflected in the final invoices paid by the customer."

As a result of this news, shares of Omnicell fell $2.14, or over 6%, on extremely heavy volume, to close at $33.08 on March 3, 2015.



If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.

Omnicell, Inc OMCL Securities Fraud Legal Help

If you have suffered from financial losses, you may qualify for damages or remedies that may be awarded in a possible Omnicell, Inc securities class action lawsuit. Please click the link below to submit your complaint for a free evaluation.